Stocks Pare Losses, Finish Down a Bit
Stocks trimmed losses late as the Dow briefly moved into positive territory after spending much of Friday in the red.
04:33PM 11/20/09
Tech Unfazed by Dismal Dell (RealMoney.com $)
Also, health care remains the top story, and ag is set for more gains.
04:19PM 11/20/09
Jim Cramer's Portfolios of the Week
Here's what Cramer's been talking about lately.
08:18AM 11/20/09
Merck Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA(R)
First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients
08:07AM 11/20/09
King, Donaldson Lead High-Flying Stocks
Canadian Solar, King Pharmaceuticals, Teck Resources and Merck hit 52-week highs.
05:00AM 11/20/09
'Fast Money' Recap: Playing Defense
The trading panel discussed moves for a market that is shifting to the downside.
07:46PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
Drugmakers' Differences: Analyst's Toolkit
Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.
05:00AM 11/18/09
Stocks Tick Up to Higher Close
U.S. stocks rise Tuesday on a mix of inflation, housing, manufacturing and retail earnings news. Gregg Greenberg surveys the day in The Real Story.
05:05PM 11/17/09
Vaccines On Horizon For AIDS, Alzheimer's, Herpes
'Golden era' could bring vaccines against AIDS, Alzheimer's and addictions within 5 years
01:48PM 11/17/09
Cramer's 'Mad Money' Recap: The Bernanke Bounce (Final)
Cramer says the Fed chairman's speech today showed once again he knows what it takes to get the economy to recover.
06:39PM 11/16/09
Beazer, Merck, Citigroup, Lowe's Are Big Movers
Beazer, Merck, Citigroup, Lowe's, Apollo Group are among big market movers Monday
05:52PM 11/16/09
Int. Trade, Big Pharma and Beleaguered Banks
Alix Steel hosts. Guests include John Maccarone, CEO of Textainer Group Holdings, Stephanie Link, director of research for Jim Cramer's Action Alerts Plus portfolio and Richard Suttmeier, chief market strategist at ValuEngine.com.
04:48PM 11/16/09
Cramer's 'Stop Trading!': Bristol-Myers
Jim Cramer discusses Intel, Boeing, Bristol-Myers and more.
03:55PM 11/16/09
Merck Shares Rise Following Niaspin-Zetia Study
Merck shares rise as Wall Street brushes off study comparing cholesterol drugs Niaspin, Zetia
01:16PM 11/16/09



Connect with TheStreet